_id
691847d03c536f8df2317867
Ticker
ZVSA
Name
ZyVersa Therapeutics Inc.
Exchange
NASDAQ
Address
2200 N. Commerce Parkway, Weston, FL, United States, 33326
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.zyversa.com
Description
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.
Last Close
0.13
Volume
162660
Current Price
0.1459
Change
0.0116
Last Updated
2026-01-08T13:25:34.627Z
Image
https://logo.clearbit.com/www.zyversa.com
Ipo Date
2022-12-12T00:00:00.000Z
Market Cap
1182004
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
20
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
20752130000
Operating Income
-20752130000
Interest Expense
131350000
Pretax Income
-18953900000
Net Income
-19805559000
Eps
-255.86336235663077
Dividends Per Share
-
Shares Outstanding
8095921
Income Tax Expense
851659000
EBITDA
-20752130000
Operating Margin
-
Total Other Income Expense Net
1798230000
Cash
527978
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
995533
Property Plant Equipment
-
Total Assets
1040260
Payables
9805129
Short Term Debt
-
Long Term Debt
-
Total Liabilities
12765827
Equity
-11725567
Bs_currency_symbol
USD
Depreciation
0
Change In Working Capital
498815
Cash From Operations
-1406912000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
1862804000
Net Change In Cash
455892000
Cf_currency_symbol
USD
PE
-
PB
-0.9631644424529747
ROE
168909.1794025824
ROA
-1903904.6969026974
FCF
-1406912000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
20752130000
Quarters > 0 > income Statement > operating Income
-20752130000
Quarters > 0 > income Statement > interest Expense
131350000
Quarters > 0 > income Statement > pretax Income
-18953900000
Quarters > 0 > income Statement > net Income
-19805559000
Quarters > 0 > income Statement > eps
-255.86336235663077
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
77406780
Quarters > 0 > income Statement > income Tax Expense
851659000
Quarters > 0 > income Statement > EBITDA
-20752130000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1798230000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
527978
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
995533
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1040260
Quarters > 0 > balance Sheet > payables
9805129
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
12765827
Quarters > 0 > balance Sheet > equity
-11725567
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-19805559000
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
498815
Quarters > 0 > cash Flow > cash From Operations
-1406912000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1862804000
Quarters > 0 > cash Flow > net Change In Cash
455892000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-255.86336235663077
Quarters > 0 > ratios > PB
-0.9631644424529747
Quarters > 0 > ratios > ROE
168909.1794025824
Quarters > 0 > ratios > ROA
-1903904.6969026974
Quarters > 0 > ratios > FCF
-1406912000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
2044132
Quarters > 1 > income Statement > operating Income
-2044132000
Quarters > 1 > income Statement > interest Expense
130036
Quarters > 1 > income Statement > pretax Income
-2211317000
Quarters > 1 > income Statement > net Income
-2211317
Quarters > 1 > income Statement > eps
-0.045934029411428684
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
48141150
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2081281
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-167185000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
72086
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
549069
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
19641111
Quarters > 1 > balance Sheet > payables
9774230
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13541337
Quarters > 1 > balance Sheet > equity
6099774
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2211317000
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
501590
Quarters > 1 > cash Flow > cash From Operations
-1521728000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-17718000
Quarters > 1 > cash Flow > net Change In Cash
-1539446000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.045934029411428684
Quarters > 1 > ratios > PB
1.1514842656465634
Quarters > 1 > ratios > ROE
-36.2524414838976
Quarters > 1 > ratios > ROA
-11.258614647613365
Quarters > 1 > ratios > FCF
-1521728000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2144571
Quarters > 2 > income Statement > operating Income
-2144571000
Quarters > 2 > income Statement > interest Expense
119559
Quarters > 2 > income Statement > pretax Income
-2256930000
Quarters > 2 > income Statement > net Income
-2256930
Quarters > 2 > income Statement > eps
-0.7264185072843657
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3106928
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2256931
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-112359000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1611532
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2110310
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
20985541
Quarters > 2 > balance Sheet > payables
9604568
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
12855191
Quarters > 2 > balance Sheet > equity
8130350
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2256930
Quarters > 2 > cash Flow > depreciation
0
Quarters > 2 > cash Flow > change In Working Capital
330987
Quarters > 2 > cash Flow > cash From Operations
-1772052000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1852660000
Quarters > 2 > cash Flow > net Change In Cash
80608000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.7264185072843657
Quarters > 2 > ratios > PB
0.0557541551347728
Quarters > 2 > ratios > ROE
-27.759321554422627
Quarters > 2 > ratios > ROA
-10.754690574810532
Quarters > 2 > ratios > FCF
-1772052000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
26078
Quarters > 3 > income Statement > cost Of Revenue
13039
Quarters > 3 > income Statement > gross Profit
13039
Quarters > 3 > income Statement > operating Expenses
1286599
Quarters > 3 > income Statement > operating Income
-1286599
Quarters > 3 > income Statement > interest Expense
138062
Quarters > 3 > income Statement > pretax Income
-1424661
Quarters > 3 > income Statement > net Income
-1421699
Quarters > 3 > income Statement > eps
-1.3099594582143186
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1085300
Quarters > 3 > income Statement > income Tax Expense
-2962
Quarters > 3 > income Statement > EBITDA
-1286599
Quarters > 3 > income Statement > operating Margin
-4933.656722141269
Quarters > 3 > income Statement > total Other Income Expense Net
-138062
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1530924
Quarters > 3 > balance Sheet > short Term Investments
1529393076
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1715797
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
20599414
Quarters > 3 > balance Sheet > payables
9337267
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
12082967
Quarters > 3 > balance Sheet > equity
8516447
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1421699
Quarters > 3 > cash Flow > depreciation
-13039
Quarters > 3 > cash Flow > change In Working Capital
-78182
Quarters > 3 > cash Flow > cash From Operations
-1224608
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2632611
Quarters > 3 > cash Flow > net Change In Cash
1408003
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.3099594582143186
Quarters > 3 > ratios > PB
0.018592879166628995
Quarters > 3 > ratios > ROE
-16.693569513201926
Quarters > 3 > ratios > ROA
-6.901647784737955
Quarters > 3 > ratios > FCF
-1224608
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-46.9594294040954
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
6933
Annuals > 0 > income Statement > gross Profit
-6933
Annuals > 0 > income Statement > operating Expenses
9129901
Annuals > 0 > income Statement > operating Income
-9136834000
Annuals > 0 > income Statement > interest Expense
269856
Annuals > 0 > income Statement > pretax Income
-9420180000
Annuals > 0 > income Statement > net Income
-9413435000
Annuals > 0 > income Statement > eps
-8480.319954451805
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1110033
Annuals > 0 > income Statement > income Tax Expense
-6745000
Annuals > 0 > income Statement > EBITDA
-9136834000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-283346000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1530924
Annuals > 0 > balance Sheet > short Term Investments
1529393076
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1715797
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
20599414
Annuals > 0 > balance Sheet > payables
9337267
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
12082967
Annuals > 0 > balance Sheet > equity
8516447
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-9413435
Annuals > 0 > cash Flow > depreciation
6933
Annuals > 0 > cash Flow > change In Working Capital
929884
Annuals > 0 > cash Flow > cash From Operations
-7559697
Annuals > 0 > cash Flow > capital Expenditures
3
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
5952947
Annuals > 0 > cash Flow > net Change In Cash
-1606750
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-8480.319954451805
Annuals > 0 > ratios > PB
0.019016593973989387
Annuals > 0 > ratios > ROE
-110532.42038610701
Annuals > 0 > ratios > ROA
-45697.58634881555
Annuals > 0 > ratios > FCF
-7559700
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
10400
Annuals > 1 > income Statement > gross Profit
-10400
Annuals > 1 > income Statement > operating Expenses
14410374
Annuals > 1 > income Statement > operating Income
-14420774
Annuals > 1 > income Statement > interest Expense
457000
Annuals > 1 > income Statement > pretax Income
-107753776
Annuals > 1 > income Statement > net Income
-98297946
Annuals > 1 > income Statement > eps
-1008.1530414448786
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
97503
Annuals > 1 > income Statement > income Tax Expense
-9455830
Annuals > 1 > income Statement > EBITDA
-107743376
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-93333000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3137674
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3353133
Annuals > 1 > balance Sheet > property Plant Equipment
14772
Annuals > 1 > balance Sheet > total Assets
22114284
Annuals > 1 > balance Sheet > payables
8431583
Annuals > 1 > balance Sheet > short Term Debt
8656
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
11039686
Annuals > 1 > balance Sheet > equity
11074598
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-98297946
Annuals > 1 > cash Flow > depreciation
10400
Annuals > 1 > cash Flow > change In Working Capital
2600444
Annuals > 1 > cash Flow > cash From Operations
-8720819
Annuals > 1 > cash Flow > capital Expenditures
1
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5956294
Annuals > 1 > cash Flow > net Change In Cash
-2764525
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1008.1530414448786
Annuals > 1 > ratios > PB
0.0012845330999825006
Annuals > 1 > ratios > ROE
-887.5983218533079
Annuals > 1 > ratios > ROA
-444.49979027130155
Annuals > 1 > ratios > FCF
-8720820
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
10400
Annuals > 2 > income Statement > gross Profit
-10400
Annuals > 2 > income Statement > operating Expenses
13822732
Annuals > 2 > income Statement > operating Income
-13833132
Annuals > 2 > income Statement > interest Expense
427542
Annuals > 2 > income Statement > pretax Income
-14867675
Annuals > 2 > income Statement > net Income
-14047607
Annuals > 2 > income Statement > eps
-541.3753275782334
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25948
Annuals > 2 > income Statement > income Tax Expense
-745050
Annuals > 2 > income Statement > EBITDA
-14429733
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1034543
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5902199
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
6362546
Annuals > 2 > balance Sheet > property Plant Equipment
115704
Annuals > 2 > balance Sheet > total Assets
118506271
Annuals > 2 > balance Sheet > payables
6025645
Annuals > 2 > balance Sheet > short Term Debt
108756
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
18511943
Annuals > 2 > balance Sheet > equity
99994328
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-14047607
Annuals > 2 > cash Flow > depreciation
9868
Annuals > 2 > cash Flow > change In Working Capital
8291886
Annuals > 2 > cash Flow > cash From Operations
-4888529
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1865384
Annuals > 2 > cash Flow > net Change In Cash
5573618
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-541.3753275782334
Annuals > 2 > ratios > PB
0.000037860279435049556
Annuals > 2 > ratios > ROE
-14.04840382546498
Annuals > 2 > ratios > ROA
-11.853893369069052
Annuals > 2 > ratios > FCF
-4888529
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
10400
Annuals > 3 > income Statement > gross Profit
-10400
Annuals > 3 > income Statement > operating Expenses
7704376
Annuals > 3 > income Statement > operating Income
-7704376
Annuals > 3 > income Statement > interest Expense
821366
Annuals > 3 > income Statement > pretax Income
-8084161
Annuals > 3 > income Statement > net Income
-8084161
Annuals > 3 > income Statement > eps
-173.65872572606978
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
46552
Annuals > 3 > income Statement > income Tax Expense
821366
Annuals > 3 > income Statement > EBITDA
-7252395
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-379785
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
328581
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
811782
Annuals > 3 > balance Sheet > property Plant Equipment
27733
Annuals > 3 > balance Sheet > total Assets
1126174
Annuals > 3 > balance Sheet > payables
2000100
Annuals > 3 > balance Sheet > short Term Debt
9151508
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
13626309
Annuals > 3 > balance Sheet > equity
-12500135
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8084161
Annuals > 3 > cash Flow > depreciation
10400
Annuals > 3 > cash Flow > change In Working Capital
-1020316
Annuals > 3 > cash Flow > cash From Operations
-5076089
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
5230000
Annuals > 3 > cash Flow > net Change In Cash
153911
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-173.65872572606978
Annuals > 3 > ratios > PB
-0.000543349075829981
Annuals > 3 > ratios > ROE
64.67258953603302
Annuals > 3 > ratios > ROA
-717.8429798592402
Annuals > 3 > ratios > FCF
-5076089
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-255.86336235663077
Valuation > metrics > PB
-0.9631644424529747
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
168909.1794025824
Profitability > metrics > ROA
-1989442.740722809
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-157.99109250095165
Risk > final Score
-602
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.10153186153899658
Liquidity > metrics > Quick Ratio
0.10153186153899658
Liquidity > final Score
15
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-62861
Prev Risks > 1
-71719
Prev Risks > 2
-7
Prev Liquidities > 0
13
Prev Liquidities > 1
21
Prev Liquidities > 2
19
Updated At
2026-01-20T22:52:08.152Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-08-13
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.46
Earnings History > 0 > eps Estimate
-0.4
Earnings History > 0 > eps Difference
-0.06
Earnings History > 0 > surprise Percent
-15
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-12
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.73
Earnings History > 1 > eps Estimate
-0.4
Earnings History > 1 > eps Difference
-0.33
Earnings History > 1 > surprise Percent
-82.5
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-27
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.31
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-14
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-2.43
Earnings History > 3 > eps Estimate
-1.6
Earnings History > 3 > eps Difference
-0.83
Earnings History > 3 > surprise Percent
-51.875
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-08-12
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-3.31
Earnings History > 4 > eps Estimate
-3.75
Earnings History > 4 > eps Difference
0.44
Earnings History > 4 > surprise Percent
11.7333
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-15
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-4.53
Earnings History > 5 > eps Estimate
-3.7
Earnings History > 5 > eps Difference
-0.83
Earnings History > 5 > surprise Percent
-22.4324
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2024-03-25
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-13.68
Earnings History > 6 > eps Estimate
-2.14
Earnings History > 6 > eps Difference
-11.54
Earnings History > 6 > surprise Percent
-539.2523
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-11-14
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.09
Earnings History > 7 > eps Estimate
-0.16
Earnings History > 7 > eps Difference
0.07
Earnings History > 7 > surprise Percent
43.75
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-08-21
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-4.8404
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-04-12
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.51
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.51
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2022-12-31
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-180.2542
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-14
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.07
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-08-15
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.04
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-04-15
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.02
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-12-22
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASurprises Report: Should I trade or invest in ZVSA - Portfolio Gains Summary & Daily Market Momentum Tracking baoquankhu1.vn
Read more →ZyVersa Therapeutics (NASDAQ:ZVSA) Shares Up 65.4% – Still a Buy? Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$20
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of ZyVersa Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.46
EPS Estimate
-0.4
EPS Difference
-0.06
Surprise Percent
-15%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.